Member
This is a set of resources to help hospitals and health systems reassure staff, patients and communities of COVID-19 vaccines’ safety and effectiveness. It includes messaging for many important audiences, whether organizational (stakeholders inside hospitals or health systems) or public-facing (…
The U.S. Department of Health and Human Services’ (HHS) Health Sector Cybersecurity Coordination Center (HC3) invites you to join its monthly webinar on November 19th. This initiative will provide actionable information on health sector cybersecurity threats and mitigations. HC3 analysts will…
Integrating Behavioral and Physical Health: How the COVID-19 Pandemic Makes this Even More Important
As a result of the pandemic, many behavioral health hospitals and service lines have created COVID-19 + treatment programs, while some general hospitals are increasing screening and treatment for behavioral health disorders.
View entire report under Key Issues.
Headlines
The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the…
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, Operation Warp Speed released an initial playbook to assist providers in planning. The playbook lays out…
The AHA Nov. 10, at 2 p.m. ET will host an all-member live virtual advocacy event.
The Centers for Medicare & Medicaid Services’ hospital price transparency final rule is effective Jan. 1, 2021. This rule, among other things, requires hospitals to disclose their privately negotiated rates with health insurers, discounted cash prices and gross charges.